VETmAb BIO is a veterinary biopharmaceutical company focused on developing monoclonal antibodies ("mAbs") to treat debilitating diseases in dogs and cats. While monoclonal antibodies have provided revolutionary treatments in humans, mAbs technology has been underdeveloped in veterinary medicine.
At VETmAb BIO, we’re taking advantage of human-validated targets and designing them specifically for dogs and cats, thereby mitigating technical risk. By utilizing our proprietary technologies, we can explore potential treatments to address various unmet needs in veterinary medicine.
Our team is comprised of experts who have decades of collective experience in mAb technology and animal health. Learn more: https://www.vetmab.bio/about/
Company Details
- Employees
- 5
- Founded
- 2022
- Address
- San Diego, Ca, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.vetmab.bio
- HQ
- San Diego, CA
Vetmab Biosciences, Inc. Questions
Vetmab Biosciences, Inc.'s website is https://www.vetmab.bio
Vetmab Biosciences, Inc.'s LinkedIn profile is https://www.linkedin.com/company/vetmab-bio
Vetmab Biosciences, Inc. has
5 employees.
View email and phone details for 5
employees at Vetmab Biosciences, Inc..
Vetmab Biosciences, Inc.'s industry is
Biotechnology Research
Vetmab Biosciences, Inc.'s top competitors are
Gallant,
Ambrosia Biolongevity,
Kindredbio,
Hilltop Bio,
Zoetis,
Connect,
Austinpx,
Invetx - A Dechra Division,
Adorapet Biosciences,
Anivc.
Vetmab Biosciences, Inc.'s categories are Biotechnology Research
Vetmab Biosciences, Inc.'s founding year is 2022
